CNTX Insider Trading Activity and SEC Form 4 Filings
CNTX insider trading summary
No open-market insider purchases or sales of Context Therapeutics Inc. (CNTX) have been reported on SEC Form 4 in the past 12 months.
Latest CNTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 9, 2025 | Martin A. Lehr | Chief Executive Officer | Buy | $70K (100,000 @ $0.70) |
| Jun 6, 2025 | Alex C. Levit | Chief Legal Officer, Corp. Sec | Buy | $12K (20,000 @ $0.58) |
| Jun 6, 2025 | Jennifer Lynn Minai-Azary | Chief Financial Officer | Buy | $25K (40,010 @ $0.64) |
| Feb 21, 2023 | Martin A. Lehr | Chief Executive Officer | Buy | $5K (5,823 @ $0.84) |
| Feb 13, 2023 | Martin A. Lehr | Chief Executive Officer | Buy | $5K (5,606 @ $0.87) |
| Feb 6, 2023 | Martin A. Lehr | Chief Executive Officer | Buy | $5K (5,040 @ $0.97) |
| Jan 30, 2023 | Martin A. Lehr | Chief Executive Officer | Buy | $5K (7,027 @ $0.70) |
| Jan 23, 2023 | Martin A. Lehr | Chief Executive Officer | Buy | $5K (6,839 @ $0.72) |
| Jan 17, 2023 | Martin A. Lehr | Chief Executive Officer | Buy | $5K (6,783 @ $0.74) |
| Dec 16, 2022 | Jennifer Lynn Minai-Azary | Chief Financial Officer | Buy | $19K (25,000 @ $0.74) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.